Literature DB >> 12673565

Chloroquine-induced phospholipidosis of the kidney mimicking Fabry's disease: case report and review of the literature.

J Müller-Höcker1, H Schmid, M Weiss, U Dendorfer, G S Braun.   

Abstract

A 46-year-old female patient with Sjögren's syndrome, hypertension, and stable chronic renal insufficiency (creatinine [CR], 1.9 to 2.1 mg/dL) had a progressive worsening of renal function (CR, 5.0 mg/dL) after 11 months of chloroquine therapy (155 mg/day; cumulative dose of approximately 51 g). Light microscopy revealed nonspecific angionephrosclerosis. Electron microscopy showed accumulations of lamellated myelinoid material and occasionally also of curvilinear bodies, especially in the glomerular podocytes and to a lesser extent in vascular myothelial and endothelial cells. In the tubular system, mainly protein droplets were stored. Activity of alpha-galactosidase A was normal in isolated leukocytes (56 nmol/mg; range, 33.2 to 109 nmol/mg), ruling out Fabry's disease. Clinical, morphological, and biochemical findings were consistent with chloroquine-associated deterioration of renal function that improved considerably after discontinuation of chloroquine treatment. Adverse effects of chloroquine may aggravate preexisting renal disease. Electron microscopy is a worthwhile tool for establishing the correct diagnosis. Copyright 2003, Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673565     DOI: 10.1053/hupa.2003.36

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  [Occurrence of chloroquine-induced myopathy after low-dose treatment of rheumatoid arthritis for seven years].

Authors:  A Haberl; P Fischer; D Pongratz; J P Sieb
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

2.  Hydroxychloroquine-induced podocytopathy mimicking Fabry disease.

Authors:  Justine Serre; David Buob; Jean-Jacques Boffa
Journal:  BMJ Case Rep       Date:  2019-05-13

3.  Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine.

Authors:  Nan Zheng; Xinyuan Zhang; Gus R Rosania
Journal:  J Pharmacol Exp Ther       Date:  2010-12-14       Impact factor: 4.030

4.  Hydroxychloroquine and Fabry Disease: Three Case Reports Examining an Unexpected Pathologic Link and a Review of the Literature.

Authors:  Rouhin Sen; Kathleen Borghoff; Kirk W Foster; Stanley J Radio; Alan Erickson; Michelene Hearth-Holmes
Journal:  Case Rep Rheumatol       Date:  2022-07-11

Review 5.  Drug induced phospholipidosis: an acquired lysosomal storage disorder.

Authors:  James A Shayman; Akira Abe
Journal:  Biochim Biophys Acta       Date:  2012-08-30

Review 6.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

7.  Renal phospholipidosis possibly induced by ranolazine.

Authors:  Christoph Scheurle; Maximilian Dämmrich; Jan U Becker; Martin W Baumgärtel
Journal:  Clin Kidney J       Date:  2013-12-10

8.  Curvilinear bodies in hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease.

Authors:  Rui M Costa; Eduardo V Martul; Juan M Reboredo; Secundino Cigarrán
Journal:  Clin Kidney J       Date:  2013-08-13

9.  Ultrastructural deposits appearing as "zebra bodies" in renal biopsy: Fabry disease?- comparative case reports.

Authors:  Precil Diego Miranda de Menezes Neves; Juliana Reis Machado; Fabiano Bichuette Custódio; Maria Luíza Gonçalves Dos Reis Monteiro; Shigueo Iwamoto; Marlene Freire; Marisa França Ferreira; Marlene Antônia Dos Reis
Journal:  BMC Nephrol       Date:  2017-05-12       Impact factor: 2.388

Review 10.  The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway.

Authors:  Frédéric Carrière; Sonia Longhi; Michel Record
Journal:  Biochimie       Date:  2020-05-30       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.